The Enterprise Value as of September 2024 (TTM) for Tango Therapeutics, Inc. (TNGX) is 873.42M

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 873.42M. This represents a change of -7.41% compared to the average of 943.30M of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical Enterprise Value (quarterly & annually)

How has TNGX Enterprise Value performed in the past?

The mean historical Enterprise Value of Tango Therapeutics, Inc. over the last ten years is 497.32M. The current 873.42M Enterprise Value has changed 17.46% with respect to the historical average. Over the past ten years (40 quarters), TNGX's Enterprise Value was at its highest in in the September 2023 quarter at 1.07B. The Enterprise Value was at its lowest in in the June 2020 quarter at 114.51M.

Tango Therapeutics, Inc. (TNGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tango Therapeutics, Inc. (TNGX) Average Enterprise Value

How has TNGX Enterprise Value performed in the past?

The current Enterprise Value of Tango Therapeutics, Inc. (TNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tango Therapeutics, Inc. (TNGX) Enterprise Value vs. Peers

How is TNGX’s Enterprise Value compared to its peers?

Tango Therapeutics, Inc.’s Enterprise Value is greater than Third Harmonic Bio, Inc. (303.08M), less than Cullinan Oncology, Inc. (886.65M), less than Edgewise Therapeutics, Inc. (1.75B), greater than Rallybio Corporation (29.25M), greater than Monte Rosa Therapeutics, Inc. (300.68M), greater than Connect Biopharma Holdings Limited (-40618512.00), less than Tyra Biosciences, Inc. (1.13B), greater than RAPT Therapeutics, Inc. (32.17M), greater than Xilio Therapeutics, Inc. (-30458906.00), greater than Mineralys Therapeutics, Inc. (513.45M), greater than Foghorn Therapeutics Inc. (430.91M), greater than Shattuck Labs, Inc. (117.33M), less than Kymera Therapeutics, Inc. (2.98B), less than Nurix Therapeutics, Inc. (1.51B), greater than TCR2 Therapeutics Inc. (49.64M), less than Revolution Medicines, Inc. (7.17B), greater than Black Diamond Therapeutics, Inc. (258.24M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (44.68M), less than Relay Therapeutics, Inc. (1.15B), greater than Stoke Therapeutics, Inc. (613.58M), greater than Pliant Therapeutics, Inc. (739.86M), less than Arvinas, Inc. (1.56B),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.